WaveMan
WaveMan · Company
GRML · Greenland Mines Ltd
> Search tickers & screens ⌘K
LIVE
← All companies

GRML Greenland Mines (GRML) Insider Trading, Ownership & Congress Trades

Pharma & Biotech · Biological products, (no diagnostic substances) · CIK 0001907223
Quote by TradingView
Cluster · 3 insidersC-suite buying · 1Form 144 · 1
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
34
13F, latest reported quarter

What the filings say about GRML

Insiders, 180 days
+$389.1K net bought
3 buyers · 1 seller · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$31.9K
1 notice

Greenland Mines insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Greenland Mines Ltd insiders bought a net $389.1K of stock across 6 Form 4 purchases and sales, with 3 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
El-Dada Riad Hussein
SELL
2026-10-05 SECtraded 2026-10-01
3,500
$32.7K
-9.2%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Jun 25, 2026.
  • No other insider sold within 30 days.
  • 34 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider El-Dada Riad Hussein sold about $32.7K of GRML on Oct 1, 2026; 34 funds added in the latest 13F quarter.
LeBlanc Jeff
Chief Financial Officer
BUY
2026-08-25 SEC
14,000
$136.1K
+14.9%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Jul 16, 2026.
  • The trade is 12.7% of the 110,406 shares held after it.
  • No other insider bought within 30 days.
  • 34 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer LeBlanc Jeff bought about $136.1K of GRML on Aug 25, 2026; 34 funds added in the latest 13F quarter.
Sawyer Jason David
Director
BUY
2026-07-23 SECtraded 2026-07-22
240,000
$55.9K
+2900.0%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 100.0% of the 240,000 shares held after it.
  • 2 other insiders bought within 30 days.
  • 34 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Sawyer Jason David bought about $55.9K of GRML on Jul 22, 2026; 2 other insiders bought within 30 days and 34 funds added in the latest 13F quarter.
McGarity Jon
Director
BUY
2026-07-20 SEC
140,000
$24.8K
+2263.3%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 25.4% of the 551,277 shares held after it.
  • 2 other insiders bought within 30 days.
  • 34 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director McGarity Jon bought about $24.8K of GRML on Jul 20, 2026; 2 other insiders bought within 30 days and 34 funds added in the latest 13F quarter.
LeBlanc Jeff
Chief Financial Officer
BUY
2026-07-17 SECtraded 2026-07-16
1,400,000
$245.3K
+2996.3%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 29.0% of the 4,820,342 shares held after it.
  • 2 other insiders bought within 30 days.
  • 34 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer LeBlanc Jeff bought about $245.3K of GRML on Jul 16, 2026, the largest insider purchase at the company on our record; 2 other insiders bought within 30 days and 34 funds added in the latest 13F quarter.
6 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 1 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net +$389.1K over 180 days
+$103.4K over 90 days
more than 84% of Pharma & Biotech
Congress
no House purchase disclosed in the last 12 months
Funds
34 funds bought in last quarter
below 60% of Pharma & Biotech
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
30.4% of the float short (float per yahoo 2026-10-26) · 1.0 days to cover · settled 2026-09-30
below 78% of Pharma & Biotech
The situation: each line is one rule over one dataset
3 insiders bought a net $389.1K, but 1 Form 144 notice ($31.9K) are queued to sell.
What changed in the last 30 days
Oct 5Insider El-Dada Riad Hussein sold $32.7K (Oct 1)
Oct 1Director Riad El-Dada filed to sell $31.9K by Oct 1 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.

Watch GRML

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+974.2%12M
-68%+842%+1752%+2663%2025-102025-122026-022026-042026-062026-082026-10 2026-07-16 · LeBlanc Jeff bought $245.3K2026-08-25 · LeBlanc Jeff bought $136.1K2026-07-22 · Sawyer Jason David bought $55.9K2026-06-25 · El-Dada Riad Hussein sold $40.2K2026-10-01 · El-Dada Riad Hussein sold $32.7K2026-07-20 · McGarity Jon bought $24.8K2026-10-01 · Riad El-Dada filed to sell $31.9K2026-06-24 · Riad El-Dada filed to sell $39.9K
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns GRML: institutional holders (13F)

13F holdings, latest reported quarter
Meteora Capital, LLC
5,373,755 sh
$1.4M
CITADEL ADVISORS LLC
5,165,648 sh
$1.3M
VANGUARD CAPITAL MANAGEMENT LLC
3,038,347 sh
$790.0K
GEODE CAPITAL MANAGEMENT, LLC
1,027,209 sh
$267.1K
Davidson Kempner Capital Management LP
1,000,000 sh
$260.0K

Congress trades in GRML

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

GRML planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
Riad El-Dada
Filed 2026-10-01
$31.9K
Riad El-Dada
Filed 2026-06-24
$39.9K

GRML mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
VANGUARD EXTENDED MARKET INDEX FUND
$387.5K position · as of 2026-06-30
0.0%
Fidelity Extended Market Index Fund
$124.3K position · as of 2026-05-31
0.0%
Total Stock Market Index Trust
$625 position · as of 2026-06-30
0.0%
Fidelity Total Market Index Fund
$54.7K position · as of 2026-05-31
0.0%
Fidelity Series Total Market Index Fund
$30.4K position · as of 2026-05-31
0.0%
Fidelity Nasdaq Composite Index Fund
$6.2K position · as of 2026-05-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
3 insiders reported buying shares.
The record shows a net $389.1K bought by insiders over 180 days, 34 funds added last quarter, $31.9K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
UTHRCPIXMRNAREGNLLYALNYMDGLCITRDNAVRTXNUVLTWST

GRML financials

Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Free cash flow, TTM
n/a
capex not filed for the four quarters
Debt to equity
0.01x
current debt only, 2022-11-30 (43 months older than the period end); equity 2026-06-30
Cash flow to debt
-47.41x
TTM operating cash flow over current debt only, 2022-11-30 (43 months older than the period end)
Return on equity
-63.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-57.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on capital employed
-50.1%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$910.7M
market value at close 2026-10-26 on 2026-08-17 shares, plus current debt only, 2022-11-30 (43 months older than the period end), minus cash 2026-06-30
FCF yield
n/a
capex not filed for the four quarters
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Operating income-$7.1M-$5.5M-$631.3K-$657.0K
Net income-$10.6M-$6.2M-$707.5K$1.2M
EPS (diluted)-0.22-0.32-0.05n/a
Operating cash flow-$5.9M-$2.9M-$446.9K-$493.0K
Cash$7.2M$63.7K$2.8K$341.0K
SEC XBRL, fiscal years, as known on 2026-10-28

GRML Stock Sonar score 5/7 axes

Find similar shapesCompare

GRML ranks highest on insider conviction (86th percentile) and financial health (46th), and lowest on risk and compliance (4th), among Pharma & Biotech peers.

ProfitHealthInsidersInstitutionsRisk
Profitability
45
Inputs
  • Return on equity-63.5% · 46 pct, sector of 545
  • Return on assets-57.4% · 39 pct, sector of 691
  • Return on invested capitaltax provision or pre-tax income not filed for the four quarters
  • Return on capital employed-50.1% · 50 pct, sector of 576
Financial health
46
Inputs
  • Debt to equity0.01x · 79 pct, sector of 352
  • Cash flow to debt-47.41x · 12 pct, sector of 371
Insider conviction
86
Inputs
  • Net Form 4 buying (codes P and S), 180d$389K · 84 pct, sector of 428
  • Insider buyers, 180d3 · 89 pct, sector of 437
Institutional and government
40
Inputs
  • Funds adding, latest quarter34 · 40 pct, sector of 698
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
4
Inputs
  • Short interest, % of float+30.4% · 4 pct, sector of 813
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
2 not measured: Growth, US patents
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

GRML filings, in plain words

Are Greenland Mines insiders buying or selling GRML?

In the 180 days to 2026-10-28, Greenland Mines insiders were net buyers, a net $389.1K: $462.1K of purchases and $73.0K of sales reported on Form 4, by 3 buyers and 1 seller.

Are there planned insider sales of GRML?

Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $31.9K of stock; the latest, by Riad El-Dada, was filed 2026-10-01.

Read the full summary

In the 180 days to 2026-10-28, Greenland Mines insiders were net buyers of GRML, a net $389.1K across purchases and sales reported on Form 4 by 3 buyers and 1 seller. 3 insiders reported purchases in that window. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $31.9K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies